£17.9 million to enhance the UK environment for advanced therapy medicinal product (ATMP) clinical trials and keep UK as a location of choice for research

  • Published on 21st March 2024 by Cell and Gene Therapy Catapult
Share

The National Institute for Health and Care Research (NIHR), Innovate UK, the Advanced Therapy Treatment Centre Network and the Cell and Gene Therapy Catapult (CGT Catapult) today announce a £17.9 million strategic initiative to enhance the UK environment for advanced therapy medicinal product (ATMP) clinical trials and to keep the UK as a location of choice for advanced therapy research.